Dr. Classen (yes, an M.D.) has patented methods for modifying vaccination schedules to reduce the risk that chronic immune-system responses and diseases such as diabetes,
Last week, the Federal Circuit decided to save a spam e-mail patent, give us a tutorial on who can host a patent infringement party (i.e.,
The Akamai and McKesson en banc briefing schedules have shifted, and the last set of briefs are now due on September 6, 2011. In these
This is the long back-story to a short order, which disposed of a big ANDA litigation. On June 13, 2011, the Supreme Court vacated the
Evidently the Virginia State Bar is taking the position that lawyers’ blogs are de facto attorney advertising, and requires a disclaimer on each post that
Duramed Pharmaceuticals, Inc. v. Paddock Laboratories, Inc., No. 2010-1419 (Fed. Cir. July 21, 2011) (Judges Lourie, Gajarsa, and Dyk) I told you a couple of
Some Interesting Patent Issues Must Percolate The question of whether Section 102(g) of the patent laws supports infringement suits involving method of use patent claims
Reckitt Benckiser Inc. v. Watson Laboratories, Inc., No. 2011-1231 (Fed. Cir. July 7, 2011) (Judges Lourie, Linn, and Dyk) When Judge Lourie sits on a
It’s chock full of information about patent and trademark cases that have been appealed to the Federal Circuit. Not enough? Unlike some blogs, we cover
Hyatt v. Kappos, 625 F.3d 1320 (Fed. Cir. 2010), cert. granted, slip op. (U.S. June 27, 2011) (No. 10-1219) Yesterday the Supreme Court agreed to
Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S, 601 F.3d 1359 (Fed. Cir. ), cert. granted, slip op. (U.S. June 27, 2011) (No. 10-844) Next
Evidently the Virginia State Bar is taking the position that lawyers’ blogs are de facto attorney advertising, and requires a disclaimer on each post that
Copyright 2024 © All rights Reserved.
